Allspring Global Investments Holdings LLC Grows Stake in Envista Holdings Co. (NYSE:NVST)

Allspring Global Investments Holdings LLC boosted its position in Envista Holdings Co. (NYSE:NVSTGet Rating) by 6.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,107 shares of the company’s stock after purchasing an additional 1,510 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Envista were worth $856,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Raymond James & Associates lifted its holdings in Envista by 6.1% in the 1st quarter. Raymond James & Associates now owns 56,493 shares of the company’s stock valued at $2,752,000 after purchasing an additional 3,235 shares in the last quarter. Bank of Montreal Can lifted its holdings in Envista by 13.9% in the 1st quarter. Bank of Montreal Can now owns 124,799 shares of the company’s stock valued at $6,103,000 after purchasing an additional 15,228 shares in the last quarter. Panagora Asset Management Inc. lifted its holdings in Envista by 8.1% in the 1st quarter. Panagora Asset Management Inc. now owns 6,543 shares of the company’s stock valued at $319,000 after purchasing an additional 490 shares in the last quarter. Great West Life Assurance Co. Can lifted its holdings in Envista by 8.6% in the 1st quarter. Great West Life Assurance Co. Can now owns 88,474 shares of the company’s stock valued at $4,433,000 after purchasing an additional 7,020 shares in the last quarter. Finally, Vontobel Holding Ltd. purchased a new position in Envista in the 1st quarter valued at about $390,000.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on NVST shares. Morgan Stanley reduced their target price on shares of Envista from $49.00 to $48.00 and set an “overweight” rating on the stock in a report on Thursday, October 13th. Piper Sandler dropped their price objective on shares of Envista from $46.00 to $44.00 and set an “overweight” rating for the company in a research note on Friday, November 4th. Finally, William Blair reaffirmed an “outperform” rating on shares of Envista in a research note on Thursday, November 3rd. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $46.17.

Envista Trading Up 1.9 %

NYSE NVST opened at $36.82 on Monday. Envista Holdings Co. has a 12 month low of $31.67 and a 12 month high of $52.03. The company has a 50-day moving average of $34.54 and a 200-day moving average of $35.85. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.09 and a quick ratio of 0.85. The company has a market cap of $6.00 billion, a P/E ratio of 25.75, a P/E/G ratio of 1.78 and a beta of 1.40.

Envista (NYSE:NVSTGet Rating) last posted its earnings results on Thursday, November 3rd. The company reported $0.47 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.47. The firm had revenue of $631.10 million during the quarter, compared to the consensus estimate of $631.94 million. Envista had a net margin of 9.98% and a return on equity of 8.33%. As a group, equities analysts predict that Envista Holdings Co. will post 1.91 earnings per share for the current year.

Envista Profile

(Get Rating)

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.

Featured Stories

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.